 Editas Medicine, Inc. NASDAQ:EDIT Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Ron Moldaver - Investor Relations Jim Mullen - Executive Chairman Gilmore ONeill - Chief Executive Officer Mark Shearman - Chief Scientific Officer Michelle Robertson - Chief Financial Officer Baisong Mei - Chief Medical Officer Conference Call Participants Gena Wang - Barclays Joon Lee - Truist Securities Dae Gon Ha - Stifel Jay Olson - Oppenheimer Luca Issi - RBC Capital Markets Rick Bienkowski - SVB Securities Philip Nadeau - Cowen and Company Joel Beatty - Robert W. Baird Yanan Zhu - Wells Fargo Securities Ryan Deschner - Raymond James Operator Good morning and welcome to Editas Medicines Second Quarter 2022 Conference Call. 